Q2 2016 Holdings
Filed 2016-08-03 | 11 holdings | $134.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Juno Therapeutics | Common Stock | 48205A109 | $47.3K | 1,229,512 | 35.1% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $36.2K | 2,600,410 | 26.8% |
| Egalet | Common Stock | 28226B104 | $14.3K | 2,889,926 | 10.6% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $13.5K | 822,175 | 10.0% |
| Nabriva Therapeutics | Sponsored ADR | 62957M104 | $8.6K | 1,145,890 | 6.4% |
| Essa Pharma | Common Stock | 29668H104 | $5.0K | 1,696,969 | 3.7% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $3.6K | 2,262,832 | 2.7% |
| Editas Medicine(EDIT) | Common Stock | 28106W103 | $2.6K | 105,008 | 1.9% |
| Proteon Therapeutics | Common Stock | 74371L109 | $2.0K | 250,000 | 1.5% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $1.1K | 606,100 | 0.8% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $670 | 223,457 | 0.5% |